NCT05487781View on ClinicalTrials.gov

Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin

EARLY_PHASE1UnknownINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

June 28, 2022

Study Completion Date

July 29, 2022

Conditions

Healthy

Interventions

COMBINATION_PRODUCT

Tirfostina/L-Carnitina

Estudio clínico fase 1 para describir la seguridad biológica y la farmacocinética de la tirfostina AG-17

Trial Locations (1)

02230

Pharmet, S.A de C.V., Mexico City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Molecule X LLC

INDUSTRY